Loss of Exclusivity - Considerations for a defense strategy in India
White Paper
Oct 23, 2019

Given the high variation in affordability and lower prices of branded generics, it creates economic incentives for physicians and patients (and payors in limited cases) to shift volume from innovator brands to generics.

The resulting rapid decline in a brand's volume and market share is the primary concern of brands facing loss of exclusivity (LoEs). While some degree of branded volume erosion due to generics seems inevitable, the extent of a brand's decline can be mitigated through strategic initiatives.

Our latest white paper explores several strategic options available to innovator companies as they prepare for upcoming LoEs and generic competition in the Indian market. An important consideration while designing an LoE strategy is to understand the impact of the LoE on evolving market dynamics. Download the complete report to know more.

Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.